MRK vs ABBV: Which Stock is Better?

Side-by-side comparison of Merck & Co Inc and Abbvie Inc in 2026

Comparison Updated:

MRK

Merck & Co Inc

$108.83

ABBV

Abbvie Inc

$214.35

Key Metrics Comparison

MetricMRKABBVWinner
Market Cap$271.83B$378.84BABBV
P/E Ratio14.40161.17MRK
EPS (TTM)$7.56$1.33MRK
Revenue Growth0.0%0.1%ABBV
Gross Margin77.9%71.5%MRK

Analyze MRK

Full quant analysis

Analyze ABBV

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is MRK or ABBV a better investment?

Comparing MRK and ABBV: Merck & Co Inc has a market cap of $271.83B while Abbvie Inc has $378.84B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between MRK and ABBV?

MRK (Merck & Co Inc) and ABBV (Abbvie Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: MRK or ABBV?

Based on P/E ratios, MRK trades at a lower multiple (14.4x vs 161.2x).

Which is growing faster: MRK or ABBV?

ABBV has higher revenue growth at 0.1% vs 0.0% for MRK.

Which company is more profitable: MRK or ABBV?

Merck & Co Inc (MRK) has higher gross margins at 77.9% compared to 71.5% for ABBV.

Which is the larger company: MRK or ABBV?

Abbvie Inc (ABBV) is larger with a market cap of $378.84B compared to $271.83B for MRK.

Should I buy MRK or ABBV in 2026?

Both MRK and ABBV have investment merit. MRK trades at $108.83 while ABBV trades at $214.35. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between MRK and ABBV stock?

Key differences: Market Cap ($271.83B vs $378.84B), P/E Ratio (14.4x vs 161.2x), Revenue Growth (0.0% vs 0.1%), Gross Margin (77.9% vs 71.5%).

Popular Stock Comparisons